Introduction
Kluyvera ascorbata is a Gram-negative microorganism belonging to the family of Enterobacteriaceae and was first identified by Farmer et al. [1] . Although it infrequently causes infections, it can cause a wide range of infections including acute appendicitis [2] ; biliary tract infection [3] ; urinary tract infection [4] ; bacteremia with neutropenia and fever [5] ; bacteremia and severe sepsis [6] ; sepsis accompanied with multiorgan dysfunction [7] ; hock and pulmonary hemorrhage [8] ; enteritis, central venous catheter infections, and peritonitis [9, 10] ; solid organ transplant recipient infection [11] ; acute cholecystitis [12] ; and cholecystitis and bacteremia [13] . However, no K. ascorbata infections have been reported to date in the oral and maxillofacial region. erefore, the authors describe the first case of a persistent postoperative infection caused by K. ascorbata in the oral and maxillofacial region after a combination of radical neck dissection with gingivectomy and mandibulectomy. A brief literature review of the clinical features of K. ascorbata infections in humans is also included.
Case Presentation
A 61-year-old Chinese man was admitted to hospital with a gingival squamous cell carcinoma of the left mandible. He was treated with a combination of radical neck dissection with gingivectomy, mandibulectomy, and strengthening of the mandible with a reconstructive plate (Figure 1 ). K. ascorbata was identified from the drainage specimen taken on postoperative day five and confirmed with the Hefei Star HX-21 blood culture analyzer (Hefei Star Technology Development Co., Ltd., Anhui, China). Antimicrobial susceptibility testing showed resistance to cefazolin and piperacillin but susceptibility to levofloxacin and gentamicin (Table 1) . K. ascorbata's ability to produce ESBLs was also detected by the same system. e patient's blood culture was sterile. Intravenous administration of levofloxacin (200 mg, q24 h) and gentamicin (240 mg, q24 h) based on the susceptibility test of this microorganism was continued for 14 days. e wounds were continuously dressed twice a day for 2 weeks and daily for 1 week. e patient was discharged home with an iodoform sponge which was changed weekly for 1 month, and the wound gradually healed after 2 months.
Discussion
K. ascorbata is a relatively newly described member of the Enterobacteriaceae family that rarely causes infections in humans. ese bacteria are usually considered a commensal [8] . Nosocomial infections pose significant threats to hospitalized patients, especially immunocompromised patients, such as those with cancer [14] . e authors report what they believe to be the first case of a multidrug-resistant K. ascorbata isolated from the wound drainage specimen of an inpatient with a postoperative infection.
K. ascorbata is virulent in terms of clinical features. It causes a wide range of infections over a wide age span, namely, from adults as old as 78 years [15] to children [9] , infants [16] , low birth weight infants [8] , and neonates as young as five days old [17] . e authors report a case involving a 61-year-old patient.
Kluyvera species can be isolated from sputum, urine, stools, and blood [18, 19] , hospital sewage [20] , human milk samples [21] , as well as wound drainage specimens as in our case. Kluyvera strains are rare but potentially dangerous pathogens due to their ability to transfer the gene encoding for ESBLs [18] , which was elucidated by Literacka et al. [22] . CTX-M beta-lactamases, which are plasmids mediated in other Enterobacteriaceae, originate from the chromosomal beta-lactamases of its reservoir, K. ascorbata. ISEcp1B, which is an insertion element [23] and a genetic mobile element [24] , has been reported to be associated with gene transfer [25, 26] . Besides bla CTX-M-3 , K. ascorbata also bears the bla TEM-1 , aacC2, and armA genes, as well as integronic aadA2, dfrA12, and sul1, which together confer resistance to the majority of beta-lactams, aminoglycosides, and trimethoprim-sulfamethoxazoles [27] . Antimicrobial agents active against Kluyvera strains include third-generation cephalosporins, fluoroquinolones, aminoglycosides [8] , beta-lactams with beta-lactamase inhibitors and carbapenems [7] , and meropenem [26] ; however, as shown by the authors, ESBL-producing K. ascorbata is resistant to penicillins and first-generation to third-generation cephalosporins. Clinicians should be aware of the spectrum of disease and the increasing clinical importance of this pathogen. Purified KLUA-9 from K. ascorbata showed the highest catalytic efficacy towards benzylpenicillin, ampicillin, piperacillin, first-generation cephalosporins, cefuroxime, and cefoperazone and the lowest efficacy towards dicloxacillin, cefoxitin, and imipenem [28] .
K. ascorbata, which is a potentially dangerous pathogen in both immunocompetent and immunocompromised Kluyvera ascorbata with the ability to produce extended spectrum betalactamases is resistant to penicillins, first-generation to third-generation cephalosporins, and most beta-lactams, even with a sensitive result in vitro.
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hosts, warrants prompt identification by antimicrobial susceptibility testing and a correct and aggressive antibiotic management [16, 29] .
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